Grimes & Company’s Align Technology ALGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.6M Sell
33,208
-522
-2% -$90.6K 0.12% 113
2026
Q1
$5.78M Buy
33,730
+8,384
+33% +$1.47M 0.16% 104
2025
Q4
$3.96M Sell
25,346
-14,670
-37% -$2.1M 0.09% 130
2025
Q3
$5.01M Sell
40,016
-5,010
-11% -$785K 0.12% 113
2025
Q2
$8.52M Buy
+45,026
New +$7.95M 0.23% 89
2019
Q4
Sell
-1,300
Closed -$235K 267
2019
Q3
$235K Buy
+1,300
New +$270K 0.02% 225

Other funds holding ALGN

Grimes & Company's ALGN Position: Q2 2026 in Review

Grimes & Company reduced its Align Technology (ALGN) stake by 1.5% in Q2 2026, selling an estimated $90.6K and leaving 33,208 shares worth $5.6M. The position accounts for 0.12% of the portfolio, ranked #113.

Grimes & Company first reported a position in ALGN in Q3 2019 and has held it in 6 quarters since. The position peaked at $8.52M in Q2 2025. 671 funds tracked by Wall St. Rank hold ALGN as of Q2 2026.

  • Grimes & Company held 33,208 shares of Align Technology worth $5.6M as of Q2 2026.
  • Grimes & Company sold 522 Align Technology shares in Q2 2026, an estimated $90.6K.
  • Align Technology made up 0.12% of Grimes & Company's portfolio in Q2 2026, its #113 holding.
  • Grimes & Company first reported a position in Align Technology in Q3 2019 and has held it in 6 quarters since.
  • Grimes & Company's Align Technology position peaked at $8.52M in Q2 2025.
  • 671 funds tracked by Wall St. Rank held Align Technology as of Q2 2026.

Based on Grimes & Company's 13F filing for Q2 2026, filed 17 Jul 2026.